Madrigal Pharmaceuticals, Inc.
MDGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001157601
In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Madrigal Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 138 | 1 | 135 | −2 |
| Shares | 12.0M | 1.71K | 11.7M | −262.0K (−2.2%) |
| Value | $857.7M | $122.2K | $763.2M | −$94.5M (−11.0%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Great Point Partners LLC | 95,500 | $6.21M | 1.49% |
| Janus Henderson Group PLC | 86,383 | $5.61M | 0.00% |
| TCG Crossover Management, LLC | 30,000 | $1.95M | 0.58% |
| Ghost Tree Capital, LLC | 25,000 | $1.63M | 0.66% |
| Point72 Asset Management, L.P. | 22,876 | $1.49M | 0.01% |
| Susquehanna International Group, LLP | 22,137 | $1.44M | 0.00% |
| Picton Mahoney Asset Management | 11,215 | $728.0K | 0.03% |
| Adage Capital Partners GP, L.L.C. | 9,100 | $591.0K | 0.00% |
| Man Group plc | 7,600 | $494.0K | 0.00% |
| Walleye Trading LLC | 3,936 | $256.0K | 0.01% |
| Teacher Retirement System of Texas | 3,909 | $254.0K | 0.00% |
| Verity Asset Management, Inc. | 3,852 | $250.3K | 0.26% |
| China Universal Asset Management Co., Ltd. | 2,598 | $169.0K | 0.07% |
| Aquatic Capital Management LLC | 2,300 | $149.0K | 0.01% |
| Money Concepts Capital Corp | 1,929 | $125.0K | 0.01% |
| Knott David M Jr | 1,000 | $65.0K | 0.03% |
| CSS LLC | 544 | $35.0K | 0.00% |
| Dark Forest Capital Management LP | 8 | $1.00K | 0.00% |
Sold out (20)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Deep Track Capital, LP | 905,000 | $64.8M |
| Jane Street Group, LLC | 27,392 | $1.96M |
| Qube Research & Technologies Ltd | 10,327 | $739.0K |
| Wolverine Trading, LLC | 6,565 | $472.0K |
| ETF Managers Group, LLC | 6,518 | $469.0K |
| Squarepoint Ops LLC | 4,074 | $292.0K |
| Virtu Financial LLC | 3,273 | $234.0K |
| DAFNA Capital Management LLC | 3,100 | $222.0K |
| Brookfield Asset Management Inc. | 3,075 | $220.0K |
| Forum Financial Management, LP | 2,976 | $213.0K |
| Altshuler Shaham Ltd | 2,135 | $153.0K |
| Silvant Capital Management LLC | 1,213 | $87.0K |
| National Bank of Canada | 180 | $13.0K |
| Captrust Financial Advisors | 173 | $12.0K |
| State of Wyoming | 128 | $9.00K |
| CoreCap Advisors, LLC | 68 | $5.00K |
| Prospera Financial Services Inc | 39 | $3.00K |
| Patriot Financial Group Insurance Agency, LLC | 20 | $1.00K |
| Quadrant Capital Group LLC | 3 | $0 |
| PEAK6 Investments LLC | 2,187 | – |
Not filed for Q3 2022 yet (1)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 1,707 | $122.2K |